Loading clinical trials...
Loading clinical trials...
Phase II Study of Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed PTCL
Conditions
Interventions
FAD
Locations
1
China
Cancer Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Start Date
November 1, 2007
Primary Completion Date
November 1, 2010
Completion Date
November 1, 2010
Last Updated
September 15, 2010
NCT07423390
NCT07435597
NCT07218874
NCT06313203
NCT06510010
NCT04724499
Lead Sponsor
Fudan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions